Premier Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $22.46 High: $23.34
on August 8, 2025

52 Week Range

Low: $17.23 High: $23.56
on March 6, 2025
on November 25, 2024

All-Time High: $47.22 on October 8, 2018

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $1.9B
EPS i 1.02
P/E Ratio (TTM) i 22.87
Forward P/E i 17.54
P/B Ratio i 1.26
PEG Ratio i 17.54
Div. Yield i 3.77%
ROE i 6.85%
Beta i 0.543
Debt to Equity i 19.35

Financial Highlights

Profitability

Gross Margin i 73.90%
Operating Margin i 18.45%
Profit Margin i 4.96%

Returns and Earnings

Return on Assets (TTM) i 4.05%
Return on Equity (TTM) i 6.85%
EBITDA i $257.0M
Net Income (TTM) i $107.0M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $12.00
Quarterly Revenue Growth (YoY) i -8.90%
Quarterly Earnings Growth (YoY) i N/A

Dividend Information

Last 12-Month Dividend i $0.84
Current Dividend Yield i 3.77%
3-Year Average Dividend Yield i 0.90%
3-Year Average Annual Dividend i $0.84
3-Year Total Dividends i $2.52
Ex-Dividend Date i May 30, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Premier PINC 1.93B Small-cap9.69%6.43%0.13%25.63%9.17%16.77%-39.29%-37.03%
Veeva Systems VEEV 46.10B Large-cap0.28%0.53%17.78%18.64%33.98%50.99%25.19%9.21%
Ge Healthcare GEHC 32.87B Large-cap3.08%-4.26%2.13%-17.71%-8.14%-13.67%26.89%26.89%
Certara CERT 1.76B Small-cap14.68%-4.04%-7.83%-21.86%2.63%-12.55%-37.70%-71.27%
10x Genomics TXG 1.56B Small-cap-6.04%0.33%42.41%1.91%-13.39%-39.84%-74.52%-88.03%
GoodRx Holdings GDRX 1.21B Small-cap-23.40%-28.31%-18.16%-30.04%-23.90%-51.87%-52.85%-93.33%

Ownership & Short Interest

Insider Ownership i 1.17%
Institutional Ownership i 96.77%
Shares Short i 11M
Short Ratio i 4.63
Short % of Shares Outstanding i 20.26%
Average 10-Day Volume i 1M
Average 90-Day Volume i 2M

Premier Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Premier would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Premier reached a high of $23.56 (on November 25, 2024) and a low of $17.23 (on March 6, 2025).
Curious about Premier's size and valuation? Its market capitalization stands at 1.93B. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.87, and the forward P/E (looking ahead) is 17.54.
Yes, Premier is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 3.77%, and the company has paid an average of $0.84 per share annually over the past 3 years.

When looking at Premier, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Veeva Systems
VEEV
46.10BHealthcareHealth Information Services50.99%25.19%
Ge Healthcare
GEHC
32.87BHealthcareHealth Information Services-13.67%26.89%
Certara
CERT
1.76BHealthcareHealth Information Services-12.55%-37.70%
10x Genomics
TXG
1.56BHealthcareHealth Information Services-39.84%-74.52%
GoodRx Holdings
GDRX
1.21BHealthcareHealth Information Services-51.87%-52.85%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Premier's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.85%, the Debt to Equity ratio from the most recent quarter is 19.35, and its Gross Profit Margin stands at 73.90%.
Looking at Premier's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -8.90%, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Premier stock? Company insiders (like executives and directors) hold about 1.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.77%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.